SEC Form 4 · accession 0001127602-15-001424
TEAM HEALTH HOLDINGS INC. · TMH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
H. Lynn Massingale
Officer — Executive Chairman · Director
Period of report
Jan 5, 2015
Accepted (ET)
Jan 8, 2015 · 11:16 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082754
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 5, 2015 | M | 60,000 | $14.93 | A | 177,123 | I | See Footnote |
| Common StockF3,F4,F2 | Jan 5, 2015 | S | 60,000 | $55.8817 | D | 117,123 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $14.93 | Jan 5, 2015 | M | 60,000 | D | — | Dec 15, 2019 | Common Stock | 60,000 | 121,973 | D |
Explanation of responses
- F1These shares were acquired and subsequently sold pursuant to a 10b5-1 Plan entered into between the shareholder and Morgan Stanley Smith Barney.
- F2These shares are held by The H. Lynn Massingale Trust, of which the Reporting Person is the trustee and sole vested beneficiary.
- F3These shares were sold pursuant to a 10b5-1 plan entered into between the shareholder and Morgan Stanley Smith Barney.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.32 to $56.72, inclusive. The reporting person undertakes to provide to Team Health Holdings, Inc., any security holder of Team Health Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5The stock options are fully vested and excercisable.